FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2751216183> ?p ?o ?g. }

• W2751216183 endingPage "17448" @default.
• W2751216183 startingPage "17431" @default.
• W2751216183 abstract "Voltage-gated Na+ (NaV) channels are key regulators of myocardial excitability, and Ca2+/calmodulin-dependent protein kinase II (CaMKII)-dependent alterations in NaV1.5 channel inactivation are emerging as a critical determinant of arrhythmias in heart failure. However, the global native phosphorylation pattern of NaV1.5 subunits associated with these arrhythmogenic disorders and the associated channel regulatory defects remain unknown. Here, we undertook phosphoproteomic analyses to identify and quantify in situ the phosphorylation sites in the NaV1.5 proteins purified from adult WT and failing CaMKIIδc-overexpressing (CaMKIIδc-Tg) mouse ventricles. Of 19 native NaV1.5 phosphorylation sites identified, two C-terminal phosphoserines at positions 1938 and 1989 showed increased phosphorylation in the CaMKIIδc-Tg compared with the WT ventricles. We then tested the hypothesis that phosphorylation at these two sites impairs fibroblast growth factor 13 (FGF13)-dependent regulation of NaV1.5 channel inactivation. Whole-cell voltage-clamp analyses in HEK293 cells demonstrated that FGF13 increases NaV1.5 channel availability and decreases late Na+ current, two effects that were abrogated with NaV1.5 mutants mimicking phosphorylation at both sites. Additional co-immunoprecipitation experiments revealed that FGF13 potentiates the binding of calmodulin to NaV1.5 and that phosphomimetic mutations at both sites decrease the interaction of FGF13 and, consequently, of calmodulin with NaV1.5. Together, we have identified two novel native phosphorylation sites in the C terminus of NaV1.5 that impair FGF13-dependent regulation of channel inactivation and may contribute to CaMKIIδc-dependent arrhythmogenic disorders in failing hearts. Voltage-gated Na+ (NaV) channels are key regulators of myocardial excitability, and Ca2+/calmodulin-dependent protein kinase II (CaMKII)-dependent alterations in NaV1.5 channel inactivation are emerging as a critical determinant of arrhythmias in heart failure. However, the global native phosphorylation pattern of NaV1.5 subunits associated with these arrhythmogenic disorders and the associated channel regulatory defects remain unknown. Here, we undertook phosphoproteomic analyses to identify and quantify in situ the phosphorylation sites in the NaV1.5 proteins purified from adult WT and failing CaMKIIδc-overexpressing (CaMKIIδc-Tg) mouse ventricles. Of 19 native NaV1.5 phosphorylation sites identified, two C-terminal phosphoserines at positions 1938 and 1989 showed increased phosphorylation in the CaMKIIδc-Tg compared with the WT ventricles. We then tested the hypothesis that phosphorylation at these two sites impairs fibroblast growth factor 13 (FGF13)-dependent regulation of NaV1.5 channel inactivation. Whole-cell voltage-clamp analyses in HEK293 cells demonstrated that FGF13 increases NaV1.5 channel availability and decreases late Na+ current, two effects that were abrogated with NaV1.5 mutants mimicking phosphorylation at both sites. Additional co-immunoprecipitation experiments revealed that FGF13 potentiates the binding of calmodulin to NaV1.5 and that phosphomimetic mutations at both sites decrease the interaction of FGF13 and, consequently, of calmodulin with NaV1.5. Together, we have identified two novel native phosphorylation sites in the C terminus of NaV1.5 that impair FGF13-dependent regulation of channel inactivation and may contribute to CaMKIIδc-dependent arrhythmogenic disorders in failing hearts." @default.
• W2751216183 created "2017-09-15" @default.
• W2751216183 creator A5001551018 @default.
• W2751216183 creator A5013302750 @default.
• W2751216183 creator A5014705357 @default.
• W2751216183 creator A5021632525 @default.
• W2751216183 creator A5041117947 @default.
• W2751216183 creator A5043503442 @default.
• W2751216183 creator A5044189301 @default.
• W2751216183 creator A5045287779 @default.
• W2751216183 creator A5046034812 @default.
• W2751216183 creator A5087985631 @default.
• W2751216183 creator A5090637595 @default.
• W2751216183 creator A5091275902 @default.
• W2751216183 date "2017-10-01" @default.
• W2751216183 modified "2023-10-13" @default.
• W2751216183 title "C-terminal phosphorylation of NaV1.5 impairs FGF13-dependent regulation of channel inactivation" @default.
• W2751216183 cites W1528710182 @default.
• W2751216183 cites W1689714005 @default.
• W2751216183 cites W1913287761 @default.
• W2751216183 cites W1920990277 @default.
• W2751216183 cites W1966093407 @default.
• W2751216183 cites W1978859761 @default.
• W2751216183 cites W1979756389 @default.
• W2751216183 cites W1998419541 @default.
• W2751216183 cites W2006700820 @default.
• W2751216183 cites W2015556811 @default.
• W2751216183 cites W2015891840 @default.
• W2751216183 cites W2024175126 @default.
• W2751216183 cites W2026945534 @default.
• W2751216183 cites W2033374878 @default.
• W2751216183 cites W2033940966 @default.
• W2751216183 cites W2061321767 @default.
• W2751216183 cites W2064163649 @default.
• W2751216183 cites W2066928228 @default.
• W2751216183 cites W2068538433 @default.
• W2751216183 cites W2072433937 @default.
• W2751216183 cites W2079916233 @default.
• W2751216183 cites W2083136627 @default.
• W2751216183 cites W2087302417 @default.
• W2751216183 cites W2095345152 @default.
• W2751216183 cites W2105658413 @default.
• W2751216183 cites W2112078820 @default.
• W2751216183 cites W2112798012 @default.
• W2751216183 cites W2120117157 @default.
• W2751216183 cites W2121234157 @default.
• W2751216183 cites W2121730912 @default.
• W2751216183 cites W2125419939 @default.
• W2751216183 cites W2131093518 @default.
• W2751216183 cites W2131624747 @default.
• W2751216183 cites W2133348233 @default.
• W2751216183 cites W2135576636 @default.
• W2751216183 cites W2147830145 @default.
• W2751216183 cites W2155446916 @default.
• W2751216183 cites W2166330292 @default.
• W2751216183 cites W2166703440 @default.
• W2751216183 cites W2168259122 @default.
• W2751216183 cites W2217152222 @default.
• W2751216183 cites W2412690797 @default.
• W2751216183 cites W2434179572 @default.
• W2751216183 cites W2528536193 @default.
• W2751216183 cites W2575931164 @default.
• W2751216183 cites W2578224578 @default.
• W2751216183 doi "https://doi.org/10.1074/jbc.m117.787788" @default.
• W2751216183 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5655519" @default.
• W2751216183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28882890" @default.
• W2751216183 hasPublicationYear "2017" @default.
• W2751216183 type Work @default.
• W2751216183 sameAs 2751216183 @default.
• W2751216183 citedByCount "23" @default.
• W2751216183 countsByYear W27512161832017 @default.
• W2751216183 countsByYear W27512161832018 @default.
• W2751216183 countsByYear W27512161832019 @default.
• W2751216183 countsByYear W27512161832020 @default.
• W2751216183 countsByYear W27512161832021 @default.
• W2751216183 countsByYear W27512161832022 @default.
• W2751216183 countsByYear W27512161832023 @default.
• W2751216183 crossrefType "journal-article" @default.
• W2751216183 hasAuthorship W2751216183A5001551018 @default.
• W2751216183 hasAuthorship W2751216183A5013302750 @default.
• W2751216183 hasAuthorship W2751216183A5014705357 @default.
• W2751216183 hasAuthorship W2751216183A5021632525 @default.
• W2751216183 hasAuthorship W2751216183A5041117947 @default.
• W2751216183 hasAuthorship W2751216183A5043503442 @default.
• W2751216183 hasAuthorship W2751216183A5044189301 @default.
• W2751216183 hasAuthorship W2751216183A5045287779 @default.
• W2751216183 hasAuthorship W2751216183A5046034812 @default.
• W2751216183 hasAuthorship W2751216183A5087985631 @default.
• W2751216183 hasAuthorship W2751216183A5090637595 @default.
• W2751216183 hasAuthorship W2751216183A5091275902 @default.
• W2751216183 hasBestOaLocation W27512161831 @default.
• W2751216183 hasConcept C104317684 @default.
• W2751216183 hasConcept C11960822 @default.
• W2751216183 hasConcept C174510640 @default.
• W2751216183 hasConcept C178790620 @default.
• W2751216183 hasConcept C181199279 @default.
• W2751216183 hasConcept C184235292 @default.
• W2751216183 hasConcept C185592680 @default.

• next